Eran Zimran

606 total citations
29 papers, 355 citations indexed

About

Eran Zimran is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Eran Zimran has authored 29 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Eran Zimran's work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Eran Zimran is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Eran Zimran collaborates with scholars based in Israel, United States and Taiwan. Eran Zimran's co-authors include Ronald Hoffman, Luena Papa, Judit Várkonyi, Tomas Ganz, Yelena Ginzburg, Mansour Djedaini, Batia Avni, Polina Stepensky, Gabriel Munter and Gideon Nesher and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Hepatology.

In The Last Decade

Eran Zimran

23 papers receiving 349 citations

Peers

Eran Zimran

HEMAT

GENET

ONCOL

IMMUN

Liwei Fang China

Gaku Oshikawa Japan

Jayashree Motwani United Kingdom

Thamer Sliwa Austria

Giuliana Alimena Italy

Nicole Kucine United States

Silvia T. Bunting United States

Lorenza Torti Italy

Erbao Ruan China

Salvatore Nicola Bertuccio Italy

Liwei Fang China

Eran Zimran

108 ×0.6

244 ×1.6

HEMAT

147 ×1.1

GENET

28 ×0.4

ONCOL

54 ×1.3

IMMUN

Citations per year, relative to Eran Zimran Eran Zimran (= 1×) peers Liwei Fang

Countries citing papers authored by Eran Zimran

Since Specialization

Citations

This map shows the geographic impact of Eran Zimran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eran Zimran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eran Zimran more than expected).

Fields of papers citing papers by Eran Zimran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eran Zimran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eran Zimran. The network helps show where Eran Zimran may publish in the future.

Co-authorship network of co-authors of Eran Zimran

This figure shows the co-authorship network connecting the top 25 collaborators of Eran Zimran. A scholar is included among the top collaborators of Eran Zimran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eran Zimran. Eran Zimran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nachmias, Boaz, Shlomo Elias, Eran Zimran, et al.. (2025). Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin. Frontiers in Immunology. 16. 1526513–1526513. 1 indexed citations

Gat, Andrea, et al.. (2025). Von Willebrand factor and JAK2V617F variant allele frequency predict thrombosis and bleeding in patients with myeloproliferative neoplasms. Annals of Hematology. 104(10). 5085–5094.

Arad, Ariela, Maya Katz, Yosef Kalish, et al.. (2025). High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T). Cancers. 17(21). 3551–3551.

Aumann, Shlomzion, Vladimir Vainstein, Ariela Arad, et al.. (2024). DNMT3A, TET2, and ASXL1 (DTA) Mutations Are Associated with Thrombosis and Bleeding in Patients with Myeloproliferative Neoplasms. Blood. 144(Supplement 1). 3189–3189. 1 indexed citations

Sugimoto, Yuka, Eran Zimran, Yoshimitsu Shimomura, et al.. (2024). A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy. Blood. 144(Supplement 1). 4569.3–4569.3.

Avni, Batia, Sigal Grisariu, Shlomo Elias, et al.. (2024). Endothelial Activation and Stress Index Score as a Prognostic Factor of Cytokine Release Syndrome in CAR-T Patients – A Retrospective Analysis of Multiple Myeloma and Large B-Cell Lymphoma Cohorts. Archivum Immunologiae et Therapiae Experimentalis. 72(1). 3 indexed citations

Zimran, Eran, et al.. (2023). Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(8). 505.e1–505.e8. 1 indexed citations

Vainstein, Vladimir, Batia Avni, Sigal Grisariu, et al.. (2023). Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?. Cancers. 15(13). 3471–3471. 8 indexed citations

Kfir‐Erenfeld, Shlomit, Batia Avni, Sigal Grisariu, et al.. (2023). Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4852–4852. 1 indexed citations

10.

Aumann, Shlomzion, Boaz Nachmias, Dina Ben Yehuda, et al.. (2023). Risk factors and outcomes of COVID‐19 in adult patients with hematological malignancies: A single‐center study showing lower than expected rates of hospitalization and mortality. European Journal Of Haematology. 111(1). 135–145. 1 indexed citations

11.

Grisariu, Sigal, Mila Rivkin, Polina Stepensky, et al.. (2023). High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients. Clinical Transplantation. 37(11). e15098–e15098. 4 indexed citations

12.

Kfir‐Erenfeld, Shlomit, Sigal Grisariu, Batia Avni, et al.. (2022). Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Clinical Cancer Research. 28(23). 5156–5166. 21 indexed citations

13.

Kfir‐Erenfeld, Shlomit, Batia Avni, Miri Assayag, et al.. (2022). Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial. Haematologica. 108(7). 1827–1839. 17 indexed citations

14.

Aumann, Shlomzion, Tsila Zuckerman, Ronit Leiba, et al.. (2022). Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study. Leukemia Research. 119. 106902–106902.

15.

Zimran, Eran, Luena Papa, & Ronald Hoffman. (2021). Ex vivo expansion of hematopoietic stem cells: Finally transitioning from the lab to the clinic. Blood Reviews. 50. 100853–100853. 27 indexed citations

16.

Zimran, Eran, Luena Papa, Mansour Djedaini, et al.. (2020). Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor. Stem Cells Translational Medicine. 9(4). 531–542. 23 indexed citations

17.

Papa, Luena, Eran Zimran, Mansour Djedaini, et al.. (2018). Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation. Blood Advances. 2(20). 2766–2779. 32 indexed citations

18.

Zimran, Eran, Ronald Hoffman, & Marina Kremyanskaya. (2018). Current approaches to challenging scenarios in myeloproliferative neoplasms. Expert Review of Anticancer Therapy. 18(6). 567–578. 7 indexed citations

19.

Zimran, Eran, Smadar Shilo, Shlomo Dotan, et al.. (2011). Paradoxical response in ocular bartonellosis. Journal of Ophthalmic Inflammation and Infection. 2(1). 53–56. 4 indexed citations

20.

Narla, Goutham, Ying‐Bei Chen, Eldad A. Hod, et al.. (2006). Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. Journal of Hepatology. 46(4). 645–654. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact